Dublin, Jan. 13, 2016 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/rf..._worldwide ) has announced the addition of the "The Worldwide Market for Bioreactors" report to their offering. The essential equipment needed for bioprocessing is the fermenter or bioreactor. Bioreactors are manufactured vessels or systems that support a biologically active environment, as cells require a very specific environment in which to grow. These bioreactors usually range in size from liters to cubic meters, and are often made of stainless steel for the large scale production of therapeutics. In the biopharmaceutical arena, smaller glass bioreactors usually are intended for research work and process development scale-up. Meanwhile, single use bioreactors, also known as disposable bioreactors, have been finding more extensive research and manufacturing use. Bioreactors can operate as batch, fed batch, or continuous stirred-tank reactor systems. The Worldwide Market for Bioreactors analyzes the current and potential world markets for bioreactors used generally for research and preclinical development applications, and for the manufacture of biopharmaceuticals. The cost of production can take on a significant role in the pricing of a biologic. Often, the selection of a bioreactor is a critical manufacturing decision. Selection is often done on a case-by-case basis and depends on production requirements. The industry's turn to single use bioreactors and related technology comes at a time when bioprocessors look to be flexible with production and to minimize costs. The report looks at significant trends in single use bioreactors. This report offers market forecasts of future growth to 2019. Both single use and stainless steel bioreactor markets are analyzed, with worldwide and geographic forecasts, including the U.S., Europe, Asia, Latin America, and rest of world.
The report takes an in-depth look at the market, providing data on the size and growth of the total market as well as of market segments:
- Single Use Bioreactor Market Share by Type of Molecule, 2014 (monoclonal antibodies, vaccines, gene therapy, recombinant proteins, stem cells, others)
- World Market for Bioreactors - Single Use Technology, 2014-2019
- World Market for Bioreactors - Single Use Technology, 2014-2019, by Geographic Segment
- World Market for Bioreactors - Single Use Technology, 2015, by Geographic Segment
- Percentage of Marketed Therapeutics by System, 2014
- Single Use Bioreactor Market Share by Vendor, 2014
- Single Use Bioreactor Usage by Process, 2014
- World Market for Bioreactors - Stainless Steel, 2014-2019
- World Market for Bioreactors - Stainless Steel, 2014-2019, by Geographic Segment
- World Market for Bioreactors - Stainless Steel, 2015, by Geographic Segment
The report profiles companies involved in developing and marketing these bioreactors, including:
- Applikon
- Danaher-Pall
- Eppendorf
- GE Healthcare
- Thermo Fisher
- Sartorius
Key Topics Covered: 1.0 Executive Summary
2.0 Introduction 2.1 A Perspective on Bioreactors 2.2 Bioreactor Variety 2.3 Single Use Systems 2.4 Attributes of Stainless Steel and Single Use Bioreactors 2.5 Challenges Facing Adoption of Single Use Bioreactors 2.6 Opportunities for Scale Up
3.0 Single Use Trends 3.1 An Enabling Strategy 3.2 Single Use Meeting Demand 3.3 Greater Use in Microbial Cultures 3.4 Increasing Product Titer 3.5 Novel Technologies Continue to Emerge 3.6 A Continuous Scenario 3.7 Modularity
4.0 Corporate Acquisitions 4.1 Danaher-Pall-ATMI 4.2 Thermo Fisher-Advanced Scientifics 4.3 Thermo Fisher-Life Technologies 4.4 Applikon Biotechnology-HaloteC 4.5 GE Healthcare-Xcellerex 4.6 Sartorius-TAP Biosystems 4.7 Sartorius-AllPure
5.0 Market Developments 5.1 Entry Level Bioreactor 5.2 New 2,000 Liter Single Use Bioreactor Running 5.3 Single Use Bioreactor for Microbial Applications 5.4 Single-Use Fermentor for Microbial Applications 5.5 First 2,000 Liter Disposable Bioreactor Run 5.6 Biotech Portfolio Acquisition 5.7 Sartorius' New Systems 5.8 Fujifilm Investments 5.9 Optimize Single Use Facilities 5.10 Next Generation Facility 5.11 2,000 Liter Introduction 5.12 Acoustic Wave Separation Technology Licensed
6.0 Market Perspective 6.1 Finding A Niche 6.2 In an Inflexible Market 6.3 Avoiding Large Capital Expenditures 6.4 Smaller Biopharmaceutical Markets 6.5 Adding Users and Markets 6.6 Changing Manufacturing Processes 6.7 Innovation Driving the Market 6.8 Market Analysis and Forecasts
7.0 Corporate Profiles 7.1 Applikon Biotechnology 7.2 Bioengineering AG 7.3 Broadley-James Corp. 7.4 Cellexus Ltd. 7.5 Celltainer Biotech BV 7.6 CerCell ApS 7.7 Electrolab Biotech Ltd. 7.8 Eppendorf 7.9 Finesse Solutions 7.10 GE Healthcare's Life Sciences Business 7.11 Heinrich Frings GmbH & Co. KG 7.12 Infors AG 7.13 Life Technologies 7.14 New MBR 7.15 Millipore 7.16 Pall Biopharm 7.17 PBS Biotech Inc. 7.18 Pierre Guerin Technologies Usine 7.19 Pluristem Therapeutics Inc. 7.20 Sartorius AG 7.21 Techniserv Inc. 7.22 Zeta Holding GmbH For more information visit http://www.researchandmarkets.com/research/rf..._worldwide
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Biotechnology
